HSG Holding’s Gyre Therapeutics GYRE Stock Holding History
Bought
Maintained
Sold
Other funds holding GYRE
HSG Holding's GYRE Position: Q3 2026 in Review
HSG Holding held its Gyre Therapeutics (GYRE) position steady in Q3 2026 at 3,750,299 shares worth $27.5M. The position accounts for 2.17% of the portfolio, ranked #8.
HSG Holding first reported a position in GYRE in Q2 2026 and has held it in 2 quarters since. 58 funds tracked by Wall St. Rank hold GYRE as of Q3 2026.
- HSG Holding held 3,750,299 shares of Gyre Therapeutics worth $27.5M as of Q3 2026.
- HSG Holding left its Gyre Therapeutics share count unchanged in Q3 2026.
- Gyre Therapeutics made up 2.17% of HSG Holding's portfolio in Q3 2026, its #8 holding.
- HSG Holding first reported a position in Gyre Therapeutics in Q2 2026 and has held it in 2 quarters since.
- 58 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q3 2026.
Based on HSG Holding's 13F filing for Q3 2026, filed 13 Nov 2026.